Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USFNB vs IV Morphine for Hip Fracture Pain in the ED
NCT02381717Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Aug 2015
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in hip fracture (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Pain intensity reduction on Visual Analog Scale (VAS) at 4 hours. Started Aug 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT02381717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02381717.